Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
NAL | why no news?? | 21/07/11 | 2 | 4.1K | |||
|
|||||||
NAL | whats happened | 30/06/11 | 7 | 5.2K | |||
|
|||||||
NAL | vote yes | 01/06/11 | 1 | 1.6K | |||
|
|||||||
NAL | Ann: Results of Meeting | 01/06/11 | 0 | 1.5K | |||
|
|||||||
NAL | Ann: Capital Raising | 09/05/11 | 2 | 2.1K | |||
|
|||||||
NAL | Ann: Prospectus | 02/05/11 | 0 | 1.7K | |||
|
|||||||
NAL | Ann: Waiver Letter from ASX | 02/05/11 | 0 | 1.3K | |||
|
|||||||
NAL | Ann: Appendix 3B | 02/05/11 | 0 | 1.4K | |||
|
See All Discussions